Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma

被引:14
|
作者
Ye, Peng [1 ]
Qu, Chang-Fa [2 ]
Hu, Xue-Lin [3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, 150 Nangang Area, Harbin 150080, Peoples R China
[3] 1 Peoples Hosp Zhangjiagang, Dept Thorac Surg, Zhangjiagang 215600, Peoples R China
关键词
Esophageal carcinoma; IGF-1; IGF-IR; IGFBP-3; Methylation; Clinicopathological features; Prognosis; BINDING PROTEIN-3 IGFBP-3; DNA METHYLATION; GROWTH; EXPRESSION; CANCER; TUMOR; GENES;
D O I
10.1007/s13277-015-4489-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study is to investigate IGF-1, IGF-1R, and IGFBP-3 methylations in esophageal carcinoma (EC) patients and their relationship with the development and prognosis of EC. This study population consisted of 264 patients (case group) whom EC radical resection was performed and 283 healthy individuals (control group). Methylation-specific PCR (MSP) detected the methylation status of IGF-1, IGF-1R, and IGFBP-3 in the peripheral blood in both groups. The expressions of IGF-1, IGF-1R, and IGFBP-3 in EC and adjacent normal tissues were detected by immunohistochemistry (IHC). The methylation rates of IGF-1, IGF-1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 in the case group were higher than those in the control group (all P<0.05). Additionally, there were statistical significances for the methylation rates of IGF-1, IGF-1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 IGF-1 among patients of different clinicopathological features (all P<0.05). The positive expression rates of IGF-1 and IGF-1R in EC were significantly higher than those in adjacent normal tissues (both P<0.001), and the rate of IGFBP-3 in EC was significantly lower than that in adjacent normal tissues (P<0.05). Correlation analysis showed that IGF-1 and IGF1R gene promoter methylation was positively correlated with the positive expressions of IGF-1 (r=0.139, P=0.024) and IGF-1R (r=0.135, P=0.028), while the IGFBP3 methylation was negatively correlated with the positive expression of IGFBP3 (r=-0.133, P=0.031). The positive expressions of IGF-1, IGF-1R, and IGFBP-3 were related to different clinicopathological features (all P<0.05). Cox multivariate analysis results showed that methylation status of IGF-1, IGF-1R, and IGF-1+IGF1R+IGFBP3 ; expressions of IGF-1 and IGF-1R protein; infiltration depth; and lymph node metastasis (LNM) were independent factors of EC prognosis. Our study demonstrated that methylation of IGF-1, IGF1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 was closely linked with the occurrence of EC and patients' clinicopathological features. Besides, the methylation status of the target genes and the expressions of IGF-1 and IGF-1R protein were independent factors of EC prognosis, which could provide a direction for the prognosis and treatment of EC.
引用
收藏
页码:6893 / 6904
页数:12
相关论文
共 50 条
  • [1] IGF-1, IGFBP-3, and cancer risk
    Holly, J
    LANCET, 2004, 364 (9431): : 325 - 326
  • [2] IGF-1 and IGFBP-3 in Inflammatory Cachexia
    Martin, Ana Isabel
    Priego, Teresa
    Moreno-Ruperez, Alvaro
    Gonzalez-Hedstrom, Daniel
    Granado, Miriam
    Lopez-Calderon, Asuncion
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [3] IGF-1, IGFBP-3, and cancer risk - Authors' reply
    Renehan, AG
    Zwahlen, M
    O'Dwyer, ST
    Shalet, SM
    Egger, M
    LANCET, 2004, 364 (9431): : 326 - 327
  • [4] Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
    Chang H.-P.
    Yang S.-F.
    Wang S.-L.
    Su P.-H.
    BMC Endocrine Disorders, 18 (1)
  • [5] Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis
    Yoon, Yeong Sook
    Keum, NaNa
    Zhang, Xuehong
    Cho, Eunyoung
    Giovannucci, Edward L.
    CANCER EPIDEMIOLOGY, 2015, 39 (06) : 1026 - 1035
  • [6] IGF-1 and IGFBP-3 in patients with liver disease
    Wallek, Grit
    Friedrich, Nele
    Ittermann, Till
    Mayerle, Julia
    Voelzke, Henry
    Nauck, Matthias
    Spielhagen, Christin
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (01): : 13 - 20
  • [7] Relation of plasma IGF-1 and IGFBP-3 to the risk of prostate cancer
    Woongeol, Y.
    Kwanjin, P.
    Seong Jin, J.
    Eunsik, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 149 - 149
  • [8] Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer
    Yamamoto, Naoto
    Oshima, Takashi
    Yoshihara, Kazue
    Aoyama, Toru
    Hayashi, Tsutomu
    Yamada, Takanobu
    Sato, Tsutoma
    Shiozawa, Manabu
    Yoshikawa, Takaki
    Morinaga, Soichiro
    Rino, Yasushi
    Kunisaki, Chikara
    Tanaka, Katsuaki
    Akaike, Makoto
    Imada, Toshio
    Masuda, Munetaka
    ONCOLOGY LETTERS, 2017, 13 (05) : 3958 - 3966
  • [9] Metabolic Fingerprints of Circulating IGF-1 and the IGF-1/IGFBP-3 Ratio: A Multifluid Metabolomics Study
    Knacke, Henrike
    Pietzner, Maik
    Kieu Trinh Do
    Roemisch-Margl, Werner
    Kastenmuller, Gabi
    Voelker, Uwe
    Voelzke, Henry
    Krumsiek, Jan
    Artati, Anna
    Wallaschofski, Henri
    Nauck, Matthias
    Suhre, Karsten
    Adamski, Jerzy
    Friedrich, Nele
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (12): : 4730 - 4742
  • [10] The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging
    Wennberg, Alexandra M. V.
    Hagen, Clinton E.
    Machulda, Mary M.
    Hollman, John H.
    Roberts, Rosebud O.
    Knopman, David S.
    Petersen, Ronald C.
    Mielke, Michelle M.
    NEUROBIOLOGY OF AGING, 2018, 66 : 68 - 74